The Department of Pharmaceuticals (DoP) has extended the date of receipt of applications till March-end for the vacant slots under Production-Linked Incentive (PLI) scheme for the promotion of domestic manufacturing of bulk drugs, an official release said recently.
The government has launched the PLI scheme to encourage domestic production of critical Key Starting Materials (KSMs)/Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs).
The DoP had issued notice on 27th January inviting applications for vacant slots (10 APIs) under PLI scheme for bulk drug with the last date of application as 13th March, 2022. “Based on the representation received from the industries/associations, the DoP has decided to extend the timeline for filling of application up to 31st March, 2022,” the Chemicals and Fertilizers ministry said in a statement.
The DoP is implementing three PLI schemes — PLI scheme for Bulk Drugs (Rs 6,940 crores), PLI scheme for Medical Devices (Rs 3,420 crores) and PLI scheme for Pharmaceuticals (Rs 15,000 crores) to promote the domestic manufacturing.
The PLI Scheme for Bulk Drugs was approved by the Cabinet in 2020.
Under two rounds of inviting applications, a total 49 of projects have been approved for 33 critical APIs with a committed investment of Rs 3,685 crores.
Edits by EP News Bureau